Cardiac hypertrophy could be broadly defined as an increase in heart mass in response to an increase in biomechanical stress. is a Prostaglandin E1 (PGE1) manufacture deadly cardiovascular disease that affects more than 23 million worldwide and more than 5 million people in North America (Bui et al. 2011 In Canada heart failure affects more… Continue reading Cardiac hypertrophy could be broadly defined as an increase in heart